eMedicine Specialties > Emergency Medicine > Endocrine & Metabolic

Alcoholic Ketoacidosis

Author: Mary Claire O'Brien, MD, Associate Professor, Department of Emergency Medicine and Department of Public Health Sciences, Wake Forest University School of Medicine
Coauthor(s): Roy Alson, MD, PhD, FACEP, FAAEM, Associate Medical Director, North Carolina Baptist AirCare; Associate Professor, Department of Emergency Medicine, Wake Forest University School of Medicine; Daniel Jobe, MD, Consulting Staff, Department of Internal Medicine, Cornerstone Health Care
Contributor Information and Disclosures

Updated: Jul 2, 2007

Introduction

Background

Alcoholic ketoacidosis (AKA) is an acute metabolic acidosis that typically occurs in people who chronically abuse alcohol and have a recent history of binge drinking, little or no food intake, and persistent vomiting. AKA is characterized by elevated serum ketone levels and a high anion gap. A concomitant metabolic alkalosis is common, secondary to vomiting and volume depletion. Although AKA most commonly occurs in adults with alcoholism, AKA has been reported in less-experienced drinkers of all ages.

Pathophysiology

AKA is a result of starvation with glycogen depletion and counter-regulatory hormone production, a raised nicotinamide adenine dinucleotide (NADH) to nicotinamide adenine dinucleotide (NAD+) ratio related to the metabolism of ethanol, and volume depletion, resulting in ketogenesis.

When the dietary intake of carbohydrates is insufficient to supply glucose for the body's needs and hepatic glycogen stores are depleted by fasting, ketones are produced in the liver as an alternative source of energy. Two steps are required for ketogenesis: (1) enhanced lipolysis with an increased delivery of free fatty acids to the liver and (2) an alteration in hepatic metabolism by which these free fatty acids are converted preferentially into ketones instead of into triglycerides. Decreased insulin activity, increased counter-regulatory hormone levels (primarily glucagon, but also cortisol, catecholamines, and growth hormone), and volume depletion all play a role in ketogenesis.

The body's response to starvation is a decrease in insulin activity and an increase in the production of counter-regulatory hormones. These counter-regulatory hormones cause the release of free fatty acids from peripheral adipose tissue. However, excess fatty acids alone are insufficient to cause ketoacidosis since, normally, the liver metabolizes free fatty acids into triglycerides. The key difference in the starvation state is in mitochondrial enzyme activity; specifically, the rate at which carnitine acyltransferase (CAT) transports free fatty acids into the mitochondria for oxidation. CAT activity is low in the fed state and accelerated in the fasting state. Glucagon excess is believed to have the major role in this hepatic response.

Prolonged vomiting leads to dehydration, which decreases renal perfusion, thereby limiting urinary excretion of ketoacids. Moreover, volume depletion increases the concentration of counter-regulatory hormones, further stimulating lipolysis and ketogenesis.

Ethanol is oxidized to acetaldehyde, which is itself oxidized to acetate. Both steps require the reduction of nicotinamide adenine dinucleotide (NAD+) to reduced nicotinamide adenine dinucleotide (NADH). The increased ratio of NADH to NAD+ has several implications: (1) impaired conversion of lactate to pyruvate with an increase in serum lactic acid levels, (2) impaired gluconeogenesis because pyruvate is not available as a substrate for glucose production, and (3) a shift in the beta-hydroxybutyrate (β-OH) to acetyl acetate (AcAc) equilibrium toward β-OH. β-OH is the predominate ketone in AKA. Understanding this is essential because routine clinical assays for ketonemia test for AcAc and acetone but not for β-OH. Clinicians underestimate the degree of ketonemia if they rely solely on the results of laboratory testing.

Frequency

United States

The prevalence of AKA in the United States correlates with the incidence and distribution of alcohol abuse within a given community.

Mortality/Morbidity

Mortality is rare. Morbidity more often results from associated complications, such as liver dysfunction, acute pancreatitis, seizures, rhabdomyolysis, hypoglycemia, lactic acidosis, heart failure, or systemic infection.

Race

No specific distribution of this disorder has been identified based on race or ethnicity.

Sex

Males and females are affected equally.

Age

AKA usually occurs in persons aged 20-60 years who are chronic abusers of alcohol. AKA occurs only rarely after a binge in persons who are not chronic drinkers.

Clinical

History

Example case of alcoholic ketoacidosis: A man who chronically drinks alcohol and has poor baseline nutritional status engages in a drinking binge. He develops nausea and vomiting and so he stops drinking and eating altogether. He presents to the emergency department 24-48 hours later. The typical symptoms may include the following:

  • Nausea, vomiting, abdominal pain, and/or hematemesis (each found in 60-75% of patients
  • Dyspnea, tremulousness, and/or dizziness (10-20% each)
  • Muscle pain, fever, diarrhea, syncope, seizure, and/or melena (1-8% each) 

Physical

Generally, the physical findings relate to volume depletion and chronic alcohol abuse. The fruity odor of ketones may be present on the patient's breath. The patient's mental status may be impaired. Physical findings may include the following:

  • Tachycardia, tachypnea, and/or abdominal tenderness (30-40% each)
  • Hypotension, hypothermia, fever, abdominal distention, rebound tenderness, hepatomegaly, ascites, and/or heme-positive stools (These are less common, with each found in 1-15% of patients.)

Causes

Most cases of AKA are related to poor nutritional status due to long-standing alcohol abuse.

More on Alcoholic Ketoacidosis

Overview: Alcoholic Ketoacidosis
Differential Diagnoses & Workup: Alcoholic Ketoacidosis
Treatment & Medication: Alcoholic Ketoacidosis
Follow-up: Alcoholic Ketoacidosis
References

References

  1. Adams SL. Alcoholic ketoacidosis. Emerg Med Clin North Am. Nov 1990;8(4):749-60. [Medline].

  2. Al-Sanouri I, Dikin M, Soubani AO. Critical care aspects of alcohol abuse. South Med J. Mar 2005;98(3):372-81. [Medline].

  3. Diltoer MW, Troubleyn J, Lauwers R, et al. Ketosis and cardiac failure: common signs of a single condition. Eur J Emerg Med. Jun 2004;11(3):172-5. [Medline].

  4. Fox JC, Whitcomb DC. Alcohol deficiency, stress hormones and bad acidosis: aka AKA. N C Med J. Feb 1991;52(2):69-73. [Medline].

  5. Halperin ML, Hammeke M, Josse RG, Jungas RL. Metabolic acidosis in the alcoholic: a pathophysiologic approach. Metabolism. Mar 1983;32(3):308-15. [Medline].

  6. Hoffman RS, Goldfrank LR. Ethanol-associated metabolic disorders. Emerg Med Clin North Am. Nov 1989;7(4):943-61. [Medline].

  7. Kearns T, Wolfson AB. Metabolic acidosis. Emerg Med Clin North Am. Nov 1989;7(4):823-35. [Medline].

  8. Moss M, Burnham EL. Alcohol abuse in the critically ill patient. Lancet. Dec 23 2006;368(9554):2231-42. [Medline].

  9. Palmer JP. Alcoholic ketoacidosis: clinical and laboratory presentation, pathophysiology and treatment. Clin Endocrinol Metab. Jul 1983;12(2):381-9. [Medline].

  10. Umpierrez GE, DiGirolamo M, Tuvlin JA. Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis. J Crit Care. Jun 2000;15(2):52-9. [Medline].

  11. Williams HE. Alcoholic hypoglycemia and ketoacidosis. Med Clin North Am. Jan 1984;68(1):33-8. [Medline].

  12. Wrenn KD, Slovis CM, Minion GE, Rutkowski R. The syndrome of alcoholic ketoacidosis. Am J Med. Aug 1991;91(2):119-28. [Medline].

Further Reading

Keywords

alcoholic ketoacidosis, AKA, alcoholic acidotic coma, alcohol withdrawal, acute metabolic acidosis, metabolic alkalosis, alcohol abuse, glycogen depletion, lipolysis, ketogenesis, ethanol consumption, ketonemia, alcoholism, chronic alcoholism, chronic alcohol abuse, ketones, substance abuse, ketosis, binge drinking, Wernicke encephalopathy, Wernicke's encephalopathy

Contributor Information and Disclosures

Author

Mary Claire O'Brien, MD, Associate Professor, Department of Emergency Medicine and Department of Public Health Sciences, Wake Forest University School of Medicine
Mary Claire O'Brien, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Roy Alson, MD, PhD, FACEP, FAAEM, Associate Medical Director, North Carolina Baptist AirCare; Associate Professor, Department of Emergency Medicine, Wake Forest University School of Medicine
Roy Alson, MD, PhD, FACEP, FAAEM is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, National Association of EMS Physicians, North Carolina Medical Society, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Daniel Jobe, MD, Consulting Staff, Department of Internal Medicine, Cornerstone Health Care
Daniel Jobe, MD is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine
Disclosure: Nothing to disclose.

Medical Editor

Erik D Schraga, MD, Consulting Staff, Permanente Medical Group, Kaiser Permanente, Santa Clara Medical Center
Erik D Schraga, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Emergency Medicine Residents Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Howard A Bessen, MD, Professor of Medicine, Department of Emergency Medicine, UCLA School of Medicine; Program Director, Harbor-UCLA Medical Center
Howard A Bessen, MD is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

CME Editor

John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School
John Halamka, MD is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Jonathan Adler, MD, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital; Division of Emergency Medicine, Harvard Medical School
Jonathan Adler, MD is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: eMedicine.com, Inc. Consulting fee Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.